Literature DB >> 15096575

The fragile X mental retardation protein has nucleic acid chaperone properties.

Caroline Gabus1, Rachid Mazroui, Sandra Tremblay, Edouard W Khandjian, Jean-Luc Darlix.   

Abstract

The fragile X syndrome is the most common cause of inherited mental retardation resulting from the absence of the fragile X mental retardation protein (FMRP). FMRP contains two K-homology (KH) domains and one RGG box that are landmarks characteristic of RNA-binding proteins. In agreement with this, FMRP associates with messenger ribonucleoparticles (mRNPs) within actively translating ribosomes, and is thought to regulate translation of target mRNAs, including its own transcript. To investigate whether FMRP might chaperone nucleic acid folding and hybridization, we analysed the annealing and strand exchange activities of DNA oligonucleotides and the enhancement of ribozyme-directed RNA substrate cleavage by FMRP and deleted variants relative to canonical nucleic acid chaperones, such as the cellular YB-1/p50 protein and the retroviral nucleocapsid protein HIV-1 NCp7. FMRP was found to possess all the properties of a potent nucleic acid chaperone, requiring the KH motifs and RGG box for optimal activity. These findings suggest that FMRP may regulate translation by acting on RNA-RNA interactions and thus on the structural status of mRNAs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15096575      PMCID: PMC407820          DOI: 10.1093/nar/gkh535

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  40 in total

1.  Characterization of the 5'-untranslated region of YB-1 mRNA and autoregulation of translation by YB-1 protein.

Authors:  Takao Fukuda; Megumi Ashizuka; Takanori Nakamura; Kotaro Shibahara; Katsumasa Maeda; Hiroto Izumi; Kimitoshi Kohno; Michihiko Kuwano; Takeshi Uchiumi
Journal:  Nucleic Acids Res       Date:  2004-01-29       Impact factor: 16.971

Review 2.  The pleiotropic functions of the Y-box-binding protein, YB-1.

Authors:  Kimitoshi Kohno; Hiroto Izumi; Takeshi Uchiumi; Megumi Ashizuka; Michihiko Kuwano
Journal:  Bioessays       Date:  2003-07       Impact factor: 4.345

3.  Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers.

Authors:  H De Rocquigny; C Gabus; A Vincent; M C Fournié-Zaluski; B Roques; J L Darlix
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

4.  Protein enhancement of hammerhead ribozyme catalysis.

Authors:  Z Tsuchihashi; M Khosla; D Herschlag
Journal:  Science       Date:  1993-10-01       Impact factor: 47.728

5.  82-FIP, a novel FMRP (fragile X mental retardation protein) interacting protein, shows a cell cycle-dependent intracellular localization.

Authors:  Barbara Bardoni; Marie Castets; Marc-Etienne Huot; Annette Schenck; Salvatore Adinolfi; François Corbin; Annalisa Pastore; Edouard W Khandjian; Jean-Louis Mandel
Journal:  Hum Mol Genet       Date:  2003-07-15       Impact factor: 6.150

6.  The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation.

Authors:  D Devys; Y Lutz; N Rouyer; J P Bellocq; J L Mandel
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

7.  NUFIP1 (nuclear FMRP interacting protein 1) is a nucleocytoplasmic shuttling protein associated with active synaptoneurosomes.

Authors:  Barbara Bardoni; Rob Willemsen; Ivan Jeanne Weiler; Annette Schenck; Lies-Anne Severijnen; Colette Hindelang; Enzo Lalli; Jean-Louis Mandel
Journal:  Exp Cell Res       Date:  2003-09-10       Impact factor: 3.905

8.  Fragile X Mental Retardation protein determinants required for its association with polyribosomal mRNPs.

Authors:  Rachid Mazroui; Marc-Etienne Huot; Sandra Tremblay; Nathalie Boilard; Yves Labelle; Edouard W Khandjian
Journal:  Hum Mol Genet       Date:  2003-10-07       Impact factor: 6.150

9.  The N-terminus of the fragile X mental retardation protein contains a novel domain involved in dimerization and RNA binding.

Authors:  S Adinolfi; A Ramos; S R Martin; F Dal Piaz; P Pucci; B Bardoni; J L Mandel; A Pastore
Journal:  Biochemistry       Date:  2003-09-09       Impact factor: 3.162

10.  G-quartet-dependent recognition between the FMRP RGG box and RNA.

Authors:  Andres Ramos; David Hollingworth; Annalisa Pastore
Journal:  RNA       Date:  2003-10       Impact factor: 4.942

View more
  37 in total

Review 1.  MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases.

Authors:  Patrick Provost
Journal:  Brain Res       Date:  2010-03-27       Impact factor: 3.252

2.  On BC1 RNA and the fragile X mental retardation protein.

Authors:  Claudia Bagni
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-15       Impact factor: 11.205

3.  Reply to Bagni: On BC1 RNA and the fragile X mental retardation protein.

Authors:  Anna Iacoangeli; Timofey S Rozhdestvensky; Natalia Dolzhanskaya; Barthélémy Tournier; Janin Schütt; Jürgen Brosius; Robert B Denman; Edouard W Khandjian; Stefan Kindler; Henri Tiedge
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-29       Impact factor: 11.205

4.  Characterization of RNA binding and chaperoning activities of HIV-1 Vif protein. Importance of the C-terminal unstructured tail.

Authors:  Dona Sleiman; Serena Bernacchi; Santiago Xavier Guerrero; Franck Brachet; Valéry Larue; Jean-Christophe Paillart; Carine Tisne
Journal:  RNA Biol       Date:  2014-07-22       Impact factor: 4.652

5.  Recombinant bacterial expression and purification of human fragile X mental retardation protein isoform 1.

Authors:  Timothy L Evans; Mihaela-Rita Mihailescu
Journal:  Protein Expr Purif       Date:  2010-06-10       Impact factor: 1.650

6.  Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles.

Authors:  Edouard W Khandjian; Marc-Etienne Huot; Sandra Tremblay; Laetitia Davidovic; Rachid Mazroui; Barbara Bardoni
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-25       Impact factor: 11.205

7.  Argonaute2 suppresses Drosophila fragile X expression preventing neurogenesis and oogenesis defects.

Authors:  Anita S-R Pepper; Rebecca W Beerman; Balpreet Bhogal; Thomas A Jongens
Journal:  PLoS One       Date:  2009-10-27       Impact factor: 3.240

8.  Differential expression of Fmr-1 mRNA and FMRP in female mice brain during aging.

Authors:  Kanchan Singh; S Prasad
Journal:  Mol Biol Rep       Date:  2007-09-27       Impact factor: 2.316

Review 9.  Translational control at the synapse: role of RNA regulators.

Authors:  Anna Iacoangeli; Henri Tiedge
Journal:  Trends Biochem Sci       Date:  2012-12-04       Impact factor: 13.807

10.  Fragile X mental retardation protein interactions with the microtubule associated protein 1B RNA.

Authors:  Lakshmi Menon; Samantha Ann Mader; Mihaela-Rita Mihailescu
Journal:  RNA       Date:  2008-06-25       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.